Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

INOVIO PHARMACEUTICALS, INC. (INO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

INOVIO PHARMACEUTICALS, INC. (INO), most recent 12 months reported: revenue $0, net loss $67.43M, free cash flow -$80.78M. Latest balance sheet on file: liquid cash $36.67M. From SEC filings. Others in Pharmaceutical Preparations: Immuneering Corporation · Immunic, Inc. · Indaptus Therapeutics, Inc. · INMED PHARMACEUTICALS INC. · Inhibitor Therapeutics, Inc. · Disc Medicine, Inc. · Incannex Healthcare Inc. · Jade Biosciences, Inc.

Stock screener

Watchlist